REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Erlangga Edi Laboratories (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Erlangga Edi Laboratories Profile Updated: February 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT Erlangga Edi Laboratories is based in Indonesia. The head office is in Ungaran. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on 1965. The latest financial highlights indicate a net sales revenue increase of 17.58% in 2022. There was a total growth of 17.77% in PT Erlangga Edi Laboratories’s total assets over the same period.

Headquarters
Kota Semarang Sumurboto Banyumanik Jawa Tengah
Ungaran; Central Java; Postal Code: 50269

Contact Details: Purchase the PT Erlangga Edi Laboratories report to view the information.

Website: http://www.erela.co.id

Basic Information
Outstanding Shares:
Purchase the PT Erlangga Edi Laboratories report to view the information.
Registered Capital:
Purchase the PT Erlangga Edi Laboratories report to view the information.
Incorporation Date:
1965
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Erlangga Edi Laboratories report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
17.58%
Total operating revenue
17.58%
Total assets
17.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?